| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/02/2004 | EP1375646A1 Genetically engineered keratinocytes expressing at least one growth factor and/or activated EGF receptor, skin equivalent comprising said keratinocytes and toxicity assay using said keratinocytes |
| 01/02/2004 | EP1375520A1 Apoptosis induced by monoclonal antibody anti-Her2 |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1375515A2 Polypeptide, cDNA encoding the same, and use thereof |
| 01/02/2004 | EP1375514A2 5'ESTs for secreted proteins expressed in various tissues |
| 01/02/2004 | EP1375512A1 Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| 01/02/2004 | EP1374998A1 Capillary printing systems |
| 01/02/2004 | EP1374997A1 Instrument and method for collecting nucleic acids |
| 01/02/2004 | EP1374910A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/02/2004 | EP1374894A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 01/02/2004 | EP1374889A1 Method of inducing angiogenesis by micro-organs |
| 01/02/2004 | EP1374879A1 Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
| 01/02/2004 | EP1374862A2 Use of a substance influencing the degree of phosphorylation of BAD for the treatment of atherosclerosis |
| 01/02/2004 | EP1374681A1 Process for identifying fungicidally active compounds |
| 01/02/2004 | EP1374134A2 Method and system for identifying commercially distributed organisms |
| 01/02/2004 | EP1373905A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents |
| 01/02/2004 | EP1373893A2 Phosphoprotein target for insulin and its antagonists |
| 01/02/2004 | EP1373890A2 Means for the identification of compounds capable of inhibiting karap-transduced signals |
| 01/02/2004 | EP1373889A2 Biosensors, reagents and diagnostic applications of directed evolution |
| 01/02/2004 | EP1373888A2 Method for screening for progesterone receptor isoform-specific ligands |
| 01/02/2004 | EP1373885A2 Methods, platforms and kits useful for identifying, isolating and utilizing nucleotide sequences which regulate gene expression in an organism |
| 01/02/2004 | EP1373870A1 Device for referencing fluorescence signals |
| 01/02/2004 | EP1373574A2 P450 single nucleotide polymorphism biochip analysis |
| 01/02/2004 | EP1373573A2 Conjugate probes and optical detection of analytes |
| 01/02/2004 | EP1373571A2 Functional surface display of polypeptides |
| 01/02/2004 | EP1373570A1 Improved in vitro synthesis system |
| 01/02/2004 | EP1373569A1 Pcr method |
| 01/02/2004 | EP1373568A2 Gene for identifying individuals with familial dysautonomia |
| 01/02/2004 | EP1373567A2 Detection of methylated cpg rich sequences diagnostic for malignant cells |
| 01/02/2004 | EP1373566A2 Polynucleotide analysis using combinatorial pcr |
| 01/02/2004 | EP1373564A2 Diagnosis of illnesses or predisposition to certain illnesses |
| 01/02/2004 | EP1373560A1 Oligonucleotide primers for the phosphatidylinositol specific phospholipase c gene and method for the detection of bacillus cereus |
| 01/02/2004 | EP1373559A2 Identification of neural defects associated with the nucleosomal assembly protein 1l2 gene |
| 01/02/2004 | EP1373558A1 Universal primers for wildlife identification |
| 01/02/2004 | EP1373546A1 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 01/02/2004 | EP1373545A2 Mch1r deficient mice |
| 01/02/2004 | EP1373544A1 A method for transfer of dna segments |
| 01/02/2004 | EP1373541A2 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated frur gene |
| 01/02/2004 | EP1373537A2 Viral vectors |
| 01/02/2004 | EP1373536A2 Lentiviral packaging constructs |
| 01/02/2004 | EP1373535A2 Improved gene expression |
| 01/02/2004 | EP1373534A2 Production of genetically modified plants with puroindolines |
| 01/02/2004 | EP1373533A2 Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity |
| 01/02/2004 | EP1373532A1 Gene encoding plant protein tm2a, conferring resistance to tomato mosaic virus |
| 01/02/2004 | EP1373531A1 Method of encoding information in nucleic acids of a genetically engineered organism |
| 01/02/2004 | EP1373530A2 Protein kinase stress-related proteins and methods of use in plants |
| 01/02/2004 | EP1373529A1 Tau-opathy model |
| 01/02/2004 | EP1373528A1 Novel expression vectors |
| 01/02/2004 | EP1373527A1 The use of double and opposite recombination sites for the single step cloning of two dna segments |
| 01/02/2004 | EP1373526A2 Therapeutic polypeptides, nucleic acids encoding same, and methodes of use |
| 01/02/2004 | EP1373525A1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof |
| 01/02/2004 | EP1373524A2 Cytomegalovirus intron a fragments |
| 01/02/2004 | EP1373523A1 Genetic modification of plants for enhanced resistance and decreased uptake of heavy metals |
| 01/02/2004 | EP1373522A2 D-carbamoylase from arthrobacter crystallopoietes dsm 20117 |
| 01/02/2004 | EP1373521A2 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 01/02/2004 | EP1373520A2 Motor proteins and methods for their use |
| 01/02/2004 | EP1373519A2 New elongase gene and production of delta-9-polyunsaturated fatty acids |
| 01/02/2004 | EP1373518A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preparation of a medicament for the treatment of metabolic disorders |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373516A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 01/02/2004 | EP1373514A2 Phosphorylation modifications of apoptin |
| 01/02/2004 | EP1373513A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/02/2004 | EP1373512A1 Fragment of l. lactis plasmid conferring antiphage activity and uses thereof |
| 01/02/2004 | EP1373511A2 Genes and proteins, and their uses |
| 01/02/2004 | EP1373510A2 Mutant allergens |
| 01/02/2004 | EP1373509A2 Desoxyribonucleic acids coding for the equine ige-allotype heavy chain constant region, the recombinant immunoglobulin obtained therewith and corresponding isotype-specific monoclonal antibodies and the utilization thereof |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373507A2 Stress-responsive activator of p300 (strap) protein |
| 01/02/2004 | EP1373506A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 01/02/2004 | EP1373505A2 Tri-hybrid melanoma antigen |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373503A2 Neurotrophic factors |
| 01/02/2004 | EP1373502A2 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 01/02/2004 | EP1373501A2 Targeting molecules for adenoviral vectors |
| 01/02/2004 | EP1373500A2 Gene involved in v(d)j recombination and/or dna repair |
| 01/02/2004 | EP1373498A2 Animal tissue with carbohydrate antigens compatible for human transplantation |
| 01/02/2004 | EP1373497A2 Method for increasing the production of a secondary metabolite in a microorganism by introducing mutations that confer antibiotic-resistance |
| 01/02/2004 | EP1373496A1 Methods for identifying peptides which modulate a biological process |
| 01/02/2004 | EP1373493A1 Coagulation factor vii derivatives |
| 01/02/2004 | EP1373492A1 Alpha-galactosidase as food-grade genetic marker |
| 01/02/2004 | EP1373490A2 Type ii thioesterase from streptomyces coelicolor a3(2) and the coding sequence |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373488A2 Heat stable mutants of starch biosynthesis enzymes |
| 01/02/2004 | EP1373487A2 Regulation of human protein kinase-like protein |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373481A1 Methods of screening for introduction of dna into a target cell |
| 01/02/2004 | EP1373480A2 Uncoupled productive and catabolic host cell pathways |
| 01/02/2004 | EP1373478A1 Attenuated live vaccine |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373476A2 Cytochrome p450s and uses thereof |
| 01/02/2004 | EP1373474A2 A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype |
| 01/02/2004 | EP1373473A1 Gene targeting methods and vectors |
| 01/02/2004 | EP1373472A1 Methods and gel compositions for encapsulating living cells and organic molecules |
| 01/02/2004 | EP1373470A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/02/2004 | EP1373469A2 Ab initio physics-based gene identification method |
| 01/02/2004 | EP1373467A1 Device and method for detection of multiple analytes |
| 01/02/2004 | EP1373322A1 Novel compound for treatment of allergy and asthma |
| 01/02/2004 | EP1373321A2 Modified antibodies and methods of use |
| 01/02/2004 | EP1373320A2 Method for preparing and selecting antibodies |
| 01/02/2004 | EP1373318A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |